Cassava Sciences Announces Over $125 Million Raised from Warrant Distribution

May 8, 2024

https://www.globenewswire.com/news-release/2024/05/08/2878016/8339/en/Cassava-Sciences-Announces-Over-125-Million-Raised-from-Warrant-Distribution.html

AUSTIN, Texas, May 08, 2024 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq:SAVA) (the “Company”), a biotechnology company focused on Alzheimer’s disease, today announced total gross proceeds of over $125 million from cash-exercises of warrants that were previously distributed to its shareholders (the “Warrants”). Gross proceeds from the Warrants represents the issuance of approximately 5.7 million common shares at an effective price of $22.00 per share.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.